| DB ID | MyCo_4071 |
| Title | Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study |
| Year | 2018 |
| PMID | 30030692 |
| Fungal Diseases involved | Candidemia |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | glabrata |
| Organism | Candida glabrata |
| Ethical Statement | This study was approved by Chongqing Medical University Biomedical Ethics Committee. All participation in the study was based on oral and written consent. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | PLT |
| Biomarker Full Name | Blood platelet count |
| Biomarker Type | Diagnostic |
| Biomolecule | None |
| Geographical Location | China |
| Cohort | A total of 198 non-duplicate candidemia episodes were identified between January 2011 and December 2016. |
| Cohort No. | 198 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | Candidemia has emerged as a life-threatening illness with high morbidity and mortality, and the burden has in- creased significantly over recent years. Previous studies on this topic have been extensively reported in the USA and Europe. Moreover, patients admitted to intensive care units (ICUs) or surgical wards have been reported to be at high risk of developing candidemia. |
| Technique | Immunological assay |
| Analysis Method | Immunological Assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | BDG Assay, PCT Assay, Immunological Assay |
| Up Regulation Down Regulation | Decrease |
| Sequence Data | None |
| External Link | None |
